Dr. Rodney Sappington has over 20 years of experience across AI/machine learning-driven technologies in medical diagnostics, drug discovery, advanced manufacturing of nanomaterials. He was one of the first to develop and deploy deep learning for early detection of high mortality cancers.
He has led world-class teams, founded and built companies, built AI/machine learning and software systems at scale, and has developed novel advanced manufacturing platforms for the optimization of nanomaterials across applications in clean water and zero gravity among others. His experience is a rare combination of AI/machine learning, clinical science, and deep tech for high impact across climate, healthcare, material science, and pharma.